PAD 0115 (Flavoxate Hydrochloride 100 mg)
Pill with imprint PAD 0115 is White, Round and has been identified as Flavoxate Hydrochloride 100 mg. It is supplied by Paddock Laboratories, Inc..
Flavoxate is used in the treatment of dysuria; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Flavoxate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PAD 0115
Flavoxate Hydrochloride
- Imprint:
- PAD 0115
- Strength:
- 100 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Paddock Laboratories, Inc.
- Inactive Ingredients:
- silicon dioxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
hypromelloses
lactose monohydrate
magnesium stearate
methyl methacrylate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromellose 2910 (6 mPa.s)
polyethylene glycol
Note: Inactive ingredients may vary.
More about flavoxate
- Flavoxate Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: urinary antispasmodics
Consumer resources
Other brands: Urispas
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
